-A A +A
December 18, 2013

In budget-constrained times, adopting new drugs or medical technology is a high-stakes challenge that requires a comprehensive, balanced approach, according to a report released today by the C.D. Howe Institute.  In “Capturing Value from Health Technologies in Lean Times,” authors Ake Blomqvist, Colin Busby and Don Husereau argue healthcare policymakers should make greater use of Health Technology Assessment (HTA), a policy tool that can help them balance demand and supply pressures for new technologies within a health-system budget.

 

Åke Blomqvist

Åke Blomqvist currently serves as a Research Fellow at the C.D. Howe Institute.

Colin Busby

Colin Busby currently serves as directeur des politiques et du développement at HEC Montréal.